01672.HK
Ascletis Pharma Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 10.09
−2.32%Next report
Analyst consensus
- Next report date
- Mar 30, 2027
- EPS estimate
- -HKD 0.49
- Revenue estimate
- HKD 48.0M
Latest reported
- Last report date
- Aug 31, 2026
- EPS actual
- -HKD 0.35
- EPS estimate
- -HKD 0.23
- Revenue actual
- —
- Revenue estimate
- HKD 31.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -53.7%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 30, 2027